Sunzen Biotech Bhd
KLSE:SUNZEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Sunzen Biotech Bhd
Gross Profit
Sunzen Biotech Bhd
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Sunzen Biotech Bhd
KLSE:SUNZEN
|
Gross Profit
29.9m
|
CAGR 3-Years
8%
|
CAGR 5-Years
30%
|
CAGR 10-Years
15%
|
|
|
D
|
Dswiss Inc
OTC:DQWS
|
Gross Profit
$564.6k
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
E
|
Eng Kah Corporation Bhd
KLSE:ENGKAH
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Karex Bhd
KLSE:KAREX
|
Gross Profit
156.2m
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
|
|
B
|
Bioalpha Holdings Bhd
KLSE:BIOHLDG
|
Gross Profit
-916k
|
CAGR 3-Years
46%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
Sunzen Biotech Bhd
Glance View
Sunzen Biotech Bhd.is an investment holding company, which engages in biotechnology research and development, and the manufacture and marketing of animal feed supplement products. The company is headquartered in Shah Alam, Selangor. The company went IPO on 2008-10-08. Its segments include Manufacturing and trading of animal health products (AH), Trading of crude palm oil products (CPO), Traditional Chinese medicines, herbal foods and beverages, bird's nest (TCM) and Loan financing. The company specializes in animal health and nutrition, manufactures and markets a range of related products for both livestock and companion animals. The company is also involved in the palm oil trading business, which entails the trading of crude palm oil and its derivative products. Its product categories include feed additive, oral pump, functional red palm oil, injectables, water soluble, detergent and disinfection and premix. Its animal health products are offered to domestic and overseas markets in countries, such as China, Korea and the Middle East.
See Also
What is Sunzen Biotech Bhd's Gross Profit?
Gross Profit
29.9m
MYR
Based on the financial report for Dec 31, 2025, Sunzen Biotech Bhd's Gross Profit amounts to 29.9m MYR.
What is Sunzen Biotech Bhd's Gross Profit growth rate?
Gross Profit CAGR 10Y
15%
Over the last year, the Gross Profit growth was 134%. The average annual Gross Profit growth rates for Sunzen Biotech Bhd have been 8% over the past three years , 30% over the past five years , and 15% over the past ten years .
